HWN Suggests

Focal Laser Ablation for Prostate Cancer: An Overview

Long-term outcomes of focal laser ablation are promising but still under investigation. Early studies suggest that many patients can enjoy a high quality of life with minimal recurrence of cancer. However, long-term data is limited, and ongoing research is crucial to understanding the full spectrum of benefits and risks.

read full article

Featured

 Focal Therapy for Prostate Cancer: Recent Advances and Insights

Focal therapy has emerged as a balanced middle ground aiming to reduce overtreatment and the risk of progression, as well as patients’ distress and anxiety. Focal therapy and partial gland ablation prioritize the precise elimination of the index lesion and a surrounding safety margin to optimize treatment outcomes and lower the risk of residual disease. The paradigm of whole-gland ablation has shifted towards more targeted approaches.

 Focal Therapy Killing the Cancer Not the Prostate

Prostate cancer is a multifocal disease: like dandelions in a field, cancer can spring up in several places within the prostate at the same time. That is why the gold standard for localized disease is to treat the entire prostate through surgery or radiation. Focal therapy – killing, or ablating, only the known spot or spots of clinically significant cancer within the prostate – has been around for decades in various forms; the most common approaches are cryo (freezing) therapy and high-intensity focused ultrasound (HIFU), and other technologies are emerging. But for years, urologists have had questions about the idea of focal therapy itself...

 Who qualifies for Focal Laser Ablation? What makes a good candidate?

There are a narrow set of patients who are good candidates for Focal Laser Ablation. When properly selected, Focal Laser Ablation produces the results that patients want without the side effects of surgery and radiation.

Articles of Interest

A Comparison of Focal Laser Ablation and Focal HIFU

Although the sample size is small, especially in the FLA report, it appears that FLA has less impact on sexual function than HIFU hemiablation. This might be explained in terms of a larger ablation zone for HIFU, since hemiablation can affect the neurovascular bundle on the treated side of the gland, thereby possibly diminishing potency. As of this writing, there are no randomized comparison studies involving two matched prostate cancer patient groups, both qualified for focal therapy, one of which receives one type of focal treatment and the other receives a different one.

Focal Laser Ablation for Localized Prostate Cancer: Principles, Clinical Trials, and Our Initial Experience

Focal therapy of prostate cancer is an evolving treatment strategy that destroys a predefined region of the prostate gland that harbors clinically significant disease. Although long-term oncologic control has yet to be demonstrated, focal therapy is associated with a marked decrease in treatment-related morbidity. Focal laser ablation is an emerging modality that has several advantages, most notably real-time magnetic resonance imaging (MRI) compatibility.

Focal laser ablation in prostate cancer: a systematic review and meta-analysis

The present systematic review and meta-analysis found that FLA provides oncological control comparable to other focal therapies while preserving functional outcomes. However, the limited availability of high-quality comparative studies highlights the need for further robust studies to validate these findings.

Laser Ablation as Focal Therapy for Prostate Cancer

While the management of prostate cancer continues to be driven by whole-gland treatment modalities, focal therapy is emerging as an increasingly desirable treatment paradigm for prostate cancer. Focal therapy of the prostate can be administered by several modalities: cryotherapy, high-intensity focused ultrasound, radiotherapy, electroporation, photodynamic therapy, and laser-induced interstitial thermal therapy (LITT or laser ablation).

Laser-focused ablative therapy for prostate cancer and benign prostatic hyperplasia: A review of current applications and future directions

Focal Laser ablation is an effective, well-tolerated, minimally invasive treatment for prostate cancer, which offers short treatment time, low complication rate, and preservation of quality of life for appropriately selected patients.

Of the focal therapies, which is the safest?

There aren’t any research studies that provide a definitive answer. We think it is the Focal Laser Ablation procedure. During the FLA, we constantly monitor all of the sensitive structures (nearby areas that can be damaged with slight changes in temperature)...

Prostate cancer laser treatment could be a gamechanger for men

This article is more than 8 years old Analysis Prostate cancer laser treatment could be a gamechanger for men This article is more than 8 years old Sarah Boseley A drug that can kill cancerous cells without the side-effects of radical surgery is causing massive excitement for good reason Tue 20 Dec 2016 11.58 EST Share 56 Prostate has long been the Cinderella of cancers, lagging behind others – in particular breast cancer – when it comes to diagnosis, treatment and the funding that goes into research. But scientists at University College London have made what they believe is a real breakthrough using a drug derived from bacteria found at the bottom of the sea, injected into the bloodstream and activated in the prostate by laser beams. There is also massive excitement from patients, who have been calling UCL ever since the news got out.